Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene

Reproductive Biology and Endocrinology

David H Barad¹  Andrea Weghofer²  Ann Kim³  Norbert Gleicher¹ 

[1] Foundation for Reproductive Medicine, New York, NY, USA;Department of Obstetrics and Gynecology, Medical University Vienna, Vienna, Austria;The Center for Human Reproduction (CHR), New York, NY, USA

关键词: In vitro fertilization;    Infertility;    FMR1 gene;    Oocyte yield;    Anti-Müllerian hormone;    Follicle stimulating hormone;    Ovarian aging;    Ovarian reserve;   

Others  :  1150067
DOI  :  10.1186/1477-7827-10-77

 received in 2012-06-25, accepted in 2012-09-04,  发布年份 2012

【 摘 要 】

Background

Ovarian aging patterns differ between races, and appear to affect fertility treatment outcomes. What causes these differences is, however, unknown. Variations in ovarian aging patterns have recently been associated with specific ovarian genotypes and sub-genotypes of the FMR1 gene. We, therefore, attempted to determine differences in how functional ovarian reserve (FOR) changes with advancing age between races, and whether changes are associated with differences in distribution of ovarian genotypes and sub-genotypes of the FMR1 gene.

Methods

We determined in association with in vitro fertilization (IVF) FOR in 62 young Caucasian, African and Asian oocyte donors and 536 older infertility patients of all three races, based on follicle stimulating hormone (FSH), anti-Müllerian hormone (AMH) and oocyte yields, and investigated whether differences between races are associated with differences in distribution of FMR1 genotypes and sub-genotypes.

Results

Changes in distribution of mean FSH, AMH and oocyte yields between young donors and older infertility patients were significant (all P < 0.001). Donors did not demonstrate significant differences between races in AMH and FSH but demonstrated significant differences in oocyte yields [F(2,59) = 4.22, P = 0.019]: Specifically, African donors demonstrated larger oocyte yields than Caucasians (P = 0.008) and Asians (P = 0.022). In patients, AMH levels differed significantly between races [F (2,533) = 4.25, P = 0.015]. Holm-Sidak post-hoc comparisons demonstrated that Caucasians demonstrated lower AMH in comparison to Asians (P = 0.007). Percentages of FMR1 genotypes and sub-genotypes in patients varied significantly between races, with Asians demonstrating fewer het-norm/low sub-genotypes than Caucasians and Africans (P = 0.012).

Conclusion

FOR changes in different races at different rates, and appears to parallel ovarian FMR1 genotypes and sub-genotype distributions. Differences in ovarian aging between races may, therefore, be FMR1-associated.

【 授权许可】

   
2012 Gleicher et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA: A new model of reproductive aging: the decline in ovarian non-growing follicle numbers from birth to menopause. Human Reprod 2008, 23:699-708.
• [2]Wallace WH, Kelsey TW: Human ovarian reserve from conception to the menopause. PLoS ONE 2010, 5:e 8772.
• [3]Gleicher N, Weghofer A, Lee IH, Barad DH: Association of FMR1 genotypes with in vitro fertilization (IVF) outcomes based on ethnicity/race. PLoS ONE 2011, 6:e18781.
• [4]Butts SF, Seifer DB: Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril 2010, 93:681-690.
• [5]Huddleston HG, Cedars MI, Sohn SH, Giudice LC, Fujimoto VY: Racial and ethnic disparities in reproductive endocrinology and infertility. Am J Obstet Gynecol 2010, 202:413-419.
• [6]Csokmay JM, Hill MJ, Maquire M, Payson MD, Fujimoto VY, Armstrong AY: Are there ethnic differences in pregnancy rates in African-American versus white women undergoing frozen blastocyst transfers? Fertil Steril 2011, 95:89-93.
• [7]Gleicher N, Weghofer A, Barad DH: Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulation ovarian ageing. Reprod Biomed Online 2010, 20:768-775.
• [8]Gleicher N, Weghofer A, Lee IH, Barad DH: FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS ONE 2010, 5:e 15303.
• [9]Gleicher N, Weghofer A, Barad DH: Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol 2011, 9:23. BioMed Central Full Text
• [10]Office of Minority Health: Final data collection standards for race, ethnicity, primary language, sex, and disability status required by section 4302 of the Affordable Care Act. US Dept of Health and Human Services Web site; 2011. http//minorityhealth.hhs.gov/templates/browse.aspx?vl=2&lvlid=208 webcite
• [11]Ledger WL: Clinical utility of measurement of anti-Müllerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 2010, 95:5144-5154.
• [12]Barad DH, Weghofer A, Gleicher N: Age-specific levels of basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007, 109:1404-1410.
• [13]Barad DH, Weghofer A, Gleicher N: Utility of age-specific serum anti-Müllerian hormone concentrations. Reprod Biomed Online 2010, 22:284-291.
• [14]Gleicher N, Barad DH: Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011, 9:67. BioMed Central Full Text
• [15]Sharara FI, McClamrock HD: Differences in in vitro fertilization (IVF) outcome between white and blackwomen in an inner-city, university-based IVF program. Fertil Steril 2000, 73:1170-1173.
• [16]Feinberg EC, Larsen FW, Catherino WH, Zhang J, Armstrong AY: Comparison of assisted reproductive technology utilization and outcomes between Caucasian and African American patients in equal-access-to-care setting. Fertil Steril 2006, 85:888-894.
• [17]Fujimoto VY, Luke B, Brown MB, Jain T, Armstrong A, Grainger DA, Hornstein MD: Racial and ethnic disparities in assisted reproductive technology outcomes in the United States. Fertile Steril 2010, 93:382-390.
• [18]Purcell K, Schembri M, Frazier LM, Rall MJ, Shen S, Croughan M, Grainger D, Fujimoto VY: Asian ethnicity is associated with reduced pregnancy outcomes after assisted reproductive technology. Fertile Steril 2007, 87:297-302.
• [19]Shuler A, Rodgers AK, Budrys NM, Holden A, Schenken RS, Brzyski RG: In vitro fertilization outcomes in Hispanics versus non-Hispanic whites. Fertil Steril 2011, 96:2735-2737.
• [20]Gleicher N, Weghofer A, Li J-M, Barad D: Differences in ovarian function parameters between Chinese and Caucasian oocyte donors: do they offer an explanation for lower IVF pregnancy rates in Chinese women? Hum Reprod 2007, 22:2879-2882.
• [21]Gleicher N, Weghofer A, Barad DH: Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Reprod Biomed Online 2010, 20:485-491.
• [22]Gleicher N, Weghofer A, Kim A, Barad DH: The impact in older women of ovarian FMR1 genotypes and sub-genotypes on ovarian reserve. PLoS ONE 2012, 7:e33638.